Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Strategy & Execution

How-tos, frameworks, omnichannel planning, and marketing roadmaps.

How AI Can Improve Clinical Trial Design and Outcomes
Posted in
  • Digital Transformation
  • Industry Landscape
  • Strategy & Execution

How AI Can Improve Clinical Trial Design and Outcomes

Clinical trials are the most expensive, time-consuming, and failure-prone phase of drug development. Despite advances in … How AI Can Improve Clinical Trial Design and OutcomesRead more

by Jayshree Gondane•February 21, 2026February 21, 2026•0
Why Pharma Sales Teams Struggle in a Digital-First World
Posted in
  • Digital Transformation
  • Industry Landscape
  • Strategy & Execution

Why Pharma Sales Teams Struggle in a Digital-First World

The pharmaceutical industry has long relied on in-person interactions between sales representatives and healthcare professionals to … Why Pharma Sales Teams Struggle in a Digital-First WorldRead more

by Jayshree Gondane•February 21, 2026February 21, 2026•0
The Hidden Costs of Failed Clinical Trials
Posted in
  • Strategy & Execution

The Hidden Costs of Failed Clinical Trials

Clinical trial failure is often framed as a scientific setback – a missed endpoint, an unexpected … The Hidden Costs of Failed Clinical TrialsRead more

by Jayshree Gondane•February 21, 2026February 21, 2026•0
Why Traditional Pharma Marketing No Longer Works
Posted in
  • Industry Landscape
  • Strategy & Execution

Why Traditional Pharma Marketing No Longer Works

The pharmaceutical industry has historically relied on a predictable playbook for bringing new therapies to market. … Why Traditional Pharma Marketing No Longer WorksRead more

by Jayshree Gondane•February 19, 2026February 19, 2026•0
How Marketing and Medical Affairs Can Work Better Together
Posted in
  • Industry Landscape
  • Strategy & Execution

How Marketing and Medical Affairs Can Work Better Together

In the modern pharmaceutical landscape, few internal relationships are as strategically important as the one between … How Marketing and Medical Affairs Can Work Better TogetherRead more

by Jayshree Gondane•February 18, 2026February 18, 2026•0
Why Clinical Trial Data Fails to Translate Into Market Success
Posted in
  • Industry Landscape
  • Strategy & Execution

Why Clinical Trial Data Fails to Translate Into Market Success

A therapy can clear Phase III, secure FDA approval, and generate headline optimism-only to miss revenue … Why Clinical Trial Data Fails to Translate Into Market SuccessRead more

by Jayshree Gondane•February 15, 2026February 15, 2026•0
How Poor Communication Between Teams Slows Drug Development
Posted in
  • Industry Landscape
  • Strategy & Execution

How Poor Communication Between Teams Slows Drug Development

Drug development is often framed as a scientific challenge. Breakthroughs hinge on molecular discovery, biomarker validation, … How Poor Communication Between Teams Slows Drug DevelopmentRead more

by Jayshree Gondane•February 15, 2026February 15, 2026•0
Why Regulatory Delays Are Only Part of the U.S. Clinical Trial Problem
Posted in
  • Regulatory Compliance
  • Strategy & Execution

Why Regulatory Delays Are Only Part of the U.S. Clinical Trial Problem

When a development program misses projected timelines, the explanation often centers on regulatory review. FDA feedback … Why Regulatory Delays Are Only Part of the U.S. Clinical Trial ProblemRead more

by Jayshree Gondane•February 15, 2026February 15, 2026•0
How Digital Marketing Can Fix Clinical Trial Recruitment Problems
Posted in
  • Digital Transformation
  • Strategy & Execution

How Digital Marketing Can Fix Clinical Trial Recruitment Problems

Clinical trial recruitment in the United States is under structural pressure. Despite record research and development … How Digital Marketing Can Fix Clinical Trial Recruitment ProblemsRead more

by Jayshree Gondane•February 15, 2026February 15, 2026•0
Why Pharma Companies Struggle With Trial Participant Retention
Posted in
  • Industry Landscape
  • Strategy & Execution

Why Pharma Companies Struggle With Trial Participant Retention

Nearly 30 percent of clinical trial participants withdraw before study completion in certain therapeutic areas, according … Why Pharma Companies Struggle With Trial Participant RetentionRead more

by Jayshree Gondane•February 15, 2026February 15, 2026•0

Posts pagination

Previous 1 … 3 4 5 … 21 Next

Recent Posts

  • Understanding Prior Authorization in Pharmaceutical Sales
  • Side Hustles for Pharmaceutical Sales Representatives
  • How to Handle Burnout in Pharmaceutical Sales
  • Work-Life Balance Tips for Pharmaceutical Sales Reps
  • Continuing Education Options for Pharma Professionals

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A